Kronenberger, Thales; Asse Junior, Leonardo Rander; Wrenger, Carsten 
; Trossini, Gustavo Henrique Goulart ; Honorio, Kathia Maria; Maltarollo, Vinícius Gonçalves
Fonte: Future Medicinal Chemistry. Unidades: EACH, ICB, FCF
Assuntos: STAPHYLOCOCCUS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, v. 9, n. 2, p. 135-151, 2017Tradução . . Disponível em: https://doi.org/10.4155/fmc-2016-0179. Acesso em: 24 abr. 2024.APA
Kronenberger, T., Asse Junior, L. R., Wrenger, C., Trossini, G. H. G., Honorio, K. M., & Maltarollo, V. G. (2017). Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, 9( 2), 135-151. doi:10.4155/fmc-2016-0179NLM
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 abr. 24 ] Available from: https://doi.org/10.4155/fmc-2016-0179Vancouver
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 abr. 24 ] Available from: https://doi.org/10.4155/fmc-2016-0179
